Show simple item record

Predicting the development of brain metastases in patients with local/regional melanoma

dc.contributor.authorFrankel, Timothy L.en_US
dc.contributor.authorBamboat, Zubin M.en_US
dc.contributor.authorAriyan, Charlotteen_US
dc.contributor.authorCoit, Danielen_US
dc.contributor.authorSabel, Michael S.en_US
dc.contributor.authorBrady, Mary S.en_US
dc.date.accessioned2014-05-23T15:59:50Z
dc.date.availableWITHHELD_14_MONTHSen_US
dc.date.available2014-05-23T15:59:50Z
dc.date.issued2014-06en_US
dc.identifier.citationFrankel, Timothy L.; Bamboat, Zubin M.; Ariyan, Charlotte; Coit, Daniel; Sabel, Michael S.; Brady, Mary S. (2014). "Predicting the development of brain metastases in patients with local/regional melanoma." Journal of Surgical Oncology 109(8): 770-774.en_US
dc.identifier.issn0022-4790en_US
dc.identifier.issn1096-9098en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106961
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherBrainen_US
dc.subject.otherMelanomaen_US
dc.subject.otherMetastasesen_US
dc.titlePredicting the development of brain metastases in patients with local/regional melanomaen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106961/1/jso23574.pdf
dc.identifier.doi10.1002/jso.23574en_US
dc.identifier.sourceJournal of Surgical Oncologyen_US
dc.identifier.citedreferenceHagen NA, Cirrincione C, Thaler HT, et al.: The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990; 40: 158 – 160.en_US
dc.identifier.citedreferenceCoit DG, Andtbacka R, Anker CJ, et al.: Melanoma. J Natl Compr Canc Netw 2012; 10: 366 – 400.en_US
dc.identifier.citedreferenceSampson JH, Carter JH Jr, Friedman AH, et al.: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88: 11 – 20.en_US
dc.identifier.citedreferenceShumate CR, Urist MM, Maddox WA: Melanoma recurrence surveillance. Patient or physician based ? Ann Surg 1995; 221: 566 – 569; discussion 569–571.en_US
dc.identifier.citedreferenceNguyen TD, DeAngelis LM: Brain metastases. Neurol Clin 2007; 25: 1173 – 1192, x–xi.en_US
dc.identifier.citedreferenceAlexander E 3rd, Moriarty TM, Davis RB, et al.: Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst 1995; 87: 34 – 40.en_US
dc.identifier.citedreferenceMorton DL, Wen DR, Wong JH, et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392 – 399.en_US
dc.identifier.citedreferenceZakrzewski J, Geraghty LN, Rose AE, et al.: Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post‐brain metastases survival. Cancer 2011; 117: 1711 – 1720.en_US
dc.identifier.citedreferenceZartman GM, Thomas MR, Robinson WA: Metastatic disease in patients with newly diagnosed malignant melanoma. J Surg Oncol 1987; 35: 163 – 164.en_US
dc.identifier.citedreferenceHarrison BE, Johnson JL, Clough RW, et al.: Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol 2003; 26: 354 – 357.en_US
dc.identifier.citedreferencede la Monte SM, Moore GW, Hutchins GM: Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983; 43: 3427 – 3433.en_US
dc.identifier.citedreferenceVogelbaum MA, Masaryk T, Mazzone P, et al.: S100beta as a predictor of brain metastases: Brain versus cerebrovascular damage. Cancer 2005; 104: 817 – 824.en_US
dc.identifier.citedreferenceMadajewicz S, Karakousis C, West CR, et al.: Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer 1984; 53: 2550 – 2552.en_US
dc.identifier.citedreferenceFidler IJ, Schackert G, Zhang RD, et al.: The biology of melanoma brain metastasis. Cancer Metastasis Rev 1999; 18: 387 – 400.en_US
dc.identifier.citedreferenceWronski M, Arbit E: Surgical treatment of brain metastases from melanoma: A retrospective study of 91 patients. J Neurosurg 2000; 93: 9 – 18.en_US
dc.identifier.citedreferenceDouglas JG, Margolin K: The treatment of brain metastases from malignant melanoma. Semin Oncol 2002; 29: 518 – 524.en_US
dc.identifier.citedreferenceVihinen P, Koskivuo I, Syrjanen K, et al.: Serum matrix metalloproteinase‐8 is associated with ulceration and vascular invasion of malignant melanoma. Melanoma Res 2008; 18: 268 – 273.en_US
dc.identifier.citedreferenceYoshida S, Takahashi H: Expression of extracellular matrix molecules in brain metastasis. J Surg Oncol 2009; 100: 65 – 68.en_US
dc.identifier.citedreferenceStark AM, Anuszkiewicz B, Mentlein R, et al.: Differential expression of matrix metalloproteinases in brain‐ and bone‐seeking clones of metastatic MDA‐MB‐231 breast cancer cells. J Neurooncol 2007; 81: 39 – 48.en_US
dc.identifier.citedreferenceXie TX, Huang FJ, Aldape KD, et al.: Activation of stat3 in human melanoma promotes brain metastasis. Cancer Res 2006; 66: 3188 – 3196.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.